6.
Maximiano T, Carneiro J, Fattori V, Verri W
. TRPV1: Receptor structure, activation, modulation and role in neuro-immune interactions and pain. Cell Calcium. 2024; 119:102870.
DOI: 10.1016/j.ceca.2024.102870.
View
7.
Marrone M, Morabito A, Giustizieri M, Chiurchiu V, Leuti A, Mattioli M
. TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun. 2017; 8:15292.
PMC: 5436240.
DOI: 10.1038/ncomms15292.
View
8.
Chapa-Oliver A, Mejia-Teniente L
. Capsaicin: From Plants to a Cancer-Suppressing Agent. Molecules. 2016; 21(8).
PMC: 6274000.
DOI: 10.3390/molecules21080931.
View
9.
Brizzi A, Aiello F, Marini P, Cascio M, Corelli F, Brizzi V
. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. Bioorg Med Chem. 2014; 22(17):4770-83.
DOI: 10.1016/j.bmc.2014.07.006.
View
10.
Adetunji T, Olawale F, Olisah C, Adetunji A, Aremu A
. Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer. Front Oncol. 2022; 12:908487.
PMC: 9326111.
DOI: 10.3389/fonc.2022.908487.
View
11.
De Petrocellis L, Moriello A, Fontana G, Sacchetti A, Passarella D, Appendino G
. Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels. Br J Pharmacol. 2013; 171(10):2608-20.
PMC: 4009003.
DOI: 10.1111/bph.12320.
View
12.
Maharjan A, Vasamsetti B, Park J
. A comprehensive review of capsaicin: Biosynthesis, industrial productions, processing to applications, and clinical uses. Heliyon. 2024; 10(21):e39721.
PMC: 11543913.
DOI: 10.1016/j.heliyon.2024.e39721.
View
13.
Knotkova H, Pappagallo M, Szallasi A
. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?. Clin J Pain. 2008; 24(2):142-54.
DOI: 10.1097/AJP.0b013e318158ed9e.
View
14.
Nozadze I, Tsiklauri N, Gurtskaia G, Tsagareli M
. Role of thermo TRPA1 and TRPV1 channels in heat, cold, and mechanical nociception of rats. Behav Pharmacol. 2015; 27(1):29-36.
DOI: 10.1097/FBP.0000000000000176.
View
15.
Brizzi A, Maramai S, Aiello F, Baratto M, Corelli F, Mugnaini C
. Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress. Int J Mol Sci. 2022; 23(21).
PMC: 9658705.
DOI: 10.3390/ijms232113580.
View
16.
Alawi K, Keeble J
. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther. 2009; 125(2):181-95.
DOI: 10.1016/j.pharmthera.2009.10.005.
View
17.
Chahl L
. TRPV1 Channels in the Central Nervous System as Drug Targets. Pharmaceuticals (Basel). 2024; 17(6).
PMC: 11206835.
DOI: 10.3390/ph17060756.
View
18.
Romeo I, Brizzi A, Pessina F, Ambrosio F, Aiello F, Belardo C
. -Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists. J Med Chem. 2023; 66(10):6994-7015.
DOI: 10.1021/acs.jmedchem.3c00447.
View
19.
Aiello F, Badolato M, Pessina F, Sticozzi C, Maestrini V, Aldinucci C
. Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide,.... ACS Chem Neurosci. 2016; 7(6):737-48.
DOI: 10.1021/acschemneuro.5b00333.
View
20.
Willis Jr W
. The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli. Exp Brain Res. 2009; 196(1):5-11.
DOI: 10.1007/s00221-009-1760-2.
View